STOCK TITAN

Xtant Medical to Issue Third Quarter 2022 Financial Results on November 3, 2022

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Xtant Medical Holdings, Inc. (NYSE American: XTNT) will release its third-quarter financial results for the period ending September 30, 2022, on November 3, 2022, before market opening. A conference call led by CEO Sean Browne and CFO Scott Neils will follow at 9:00 AM ET to discuss these results. Investors are encouraged to participate via dial-in or web registration, with a replay available thereafter on the company's website.

Xtant Medical focuses on innovative surgical solutions for spinal disorders.

Positive
  • Upcoming financial results announcement for Q3 2022 shows company transparency.
  • Conference call scheduled to provide direct insights into performance.
Negative
  • None.

BELGRADE, Mont., Oct. 27, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the third quarter ended September 30, 2022, before the open of the financial markets on Thursday, November 3, 2022.

Sean Browne, President and Chief Executive Officer, and Scott Neils, Chief Financial Officer, will host a conference call on Thursday, November 3 at 9:00 AM ET to review results.

Conference Details
Conference Date: Thursday, November 3, 2022 - 9:00 AM ET
Conference dial-in: 877-407-6184
International dial-in: 201-389-0877
Conference Call Name: Xtant Medical Q3 2022 Financial Results
Webcast Registration: Click Here

Following the live call, a replay will be available on the Company’s website, www.xtantmedical.com, under “Investor Info.”

About Xtant Medical Holdings, Inc.

Xtant Medical Holdings, Inc. (www.xtantmedical.com) is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Xtant people are dedicated and talented, operating with the highest integrity to serve our customers.

The symbols ™ and ® denote trademarks and registered trademarks of Xtant Medical Holdings, Inc. or its affiliates, registered as indicated in the United States, and in other countries. All other trademarks and trade names referred to in this release are the property of their respective owners.

Investor Relations Contact

David Carey
Lazar FINN Partners
Ph: 212-867-1762
Email: david.carey@finnpartners.com


FAQ

When will Xtant Medical release its financial results for Q3 2022?

Xtant Medical will release its financial results for the third quarter on November 3, 2022.

What time is the Xtant Medical Q3 2022 conference call?

The conference call is scheduled for November 3, 2022, at 9:00 AM ET.

How can I attend the Xtant Medical conference call?

You can attend the conference call by dialing 877-407-6184 or 201-389-0877 for international participants.

Where can I find the replay of the Xtant Medical Q3 2022 conference call?

The replay of the conference call will be available on Xtant Medical's website under the 'Investor Info' section.

Xtant Medical Holdings, Inc.

NYSE:XTNT

XTNT Rankings

XTNT Latest News

XTNT Stock Data

49.13M
55.14M
7.83%
65.12%
0.14%
Medical Devices
Biological Products, (no Disgnostic Substances)
Link
United States of America
BELGRADE